Recently, potentiation of NO signaling through inhibition of phosphodiesterase 5 (PDE5) has shown effectiveness in preventing cardiac hypertrophy and heart failure induced by pressure overload in animal models as well as, promising for human heart failure, diabetic cardiomyopathy, and pulmonary hypertension [43]. This evidence concerns the gene PDE5A and cardiac hypertrophy.